TABLE 6.
spa-CCa | spa type | No. of PTsb | No. of isolatesc | Patient |
---|---|---|---|---|
CC003 | t003 | 16 | 123 | 13 |
CC211 | t008 | 10 | 140 | 3 |
CC211 | t206 | 5 | 112 | 7 |
CC5430 | t5430 | 9 | 123 | 4 |
CC5430 | t166 | 3 | 160 | 6 |
CC617 | t1577 | 8 | 152 | 2 |
CC617 | t617 | 11 | 152 | 10 |
CC618 | t021 | 6 | 160 | 5 |
No founder – cluster 7 | t002 | 11 | 195 | 9 |
No founder – cluster 7 | t067 | 3 | 102 | 14 |
No founder – cluster 9 | t034 | 2 | 119 | 8 |
No founder – cluster 9 | t011 | 5 | 123 | 12 |
Singleton | t091 | 5 | 192 | 1 |
Singleton | t091 | 9 | 197 | 11 |
BURP analysis clustered spa types into clonal clusters (spa-CCs) depending on the repeat succession within the repeat region of protein A. “No founder” indicates that the repeat succession of spa types is very similar, but a founder could not be determined. However, the spa types belong to specific clusters. “Singleton” indicates that in the studied S. aureus isolate collection, no isolates with related sequences within the repeat region were found.
PTs, the number of different PTs within the spa type of the individual patients.
Number of isolates of the respective spa type for the individual patient.